Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16826030 | 0.79 | KDM4E (0.42) | KDM4EALDH1A1MAPTBLMIDO1 | |
| SCHEMBL13662717 | 0.79 | CCR1 (0.57) | KDM4EALDH1A1MAPTBLM | |
| SCHEMBL4390590 | 0.76 | CCR1 (0.46) | KDM4EALDH1A1BLM | |
| SCHEMBL31215055 | 0.76 | KDM4E (0.46) | KDM4EALDH1A1MAPTBLM | |
| SCHEMBL13659749 | 0.75 | ALDH1A1 (0.39) | KDM4EALDH1A1MAPTBLM | |
| SCHEMBL22926102 | 0.75 | NPSR1 (0.42) | KDM4EALDH1A1MAPTBLM | |
| SCHEMBL23504950 | 0.66 | CYP11B1 (0.43) | KDM4EALDH1A1MAPTBLM | |
| SCHEMBL20371178 | 0.65 | CCR1 (0.36) | — | |
| SCHEMBL16847996 | 0.64 | MAPT (0.46) | KDM4EALDH1A1MAPTBLM | |
| SCHEMBL20390109 | 0.63 | ADORA3 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713306-A1 | NOVEL TRACER FOR THE IN VIVO DETECTION OF THE AGGREGATION OF ALPHA-SYNUCLEIN | Stichting Amsterdam UMC (NL) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024236054-A1 | NOVEL TRACER FOR THE IN VIVO DETECTION OF THE AGGREGATION OF ALPHA-SYNUCLEIN | Stichting Amsterdam UMC (NL) | 2024-11-21 | — | — | WO | disclosed |